Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Risk of cervical cancer after HPV vaccination.

Markman M.

Curr Pharm Des. 2013;19(8):1488-9.

PMID:
23016781
2.

Human papillomavirus, vaccines, and protection from cervical cancer.

Altinbas SK, Tapisiz OL.

Saudi Med J. 2012 Dec;33(12):1270-7. Review.

PMID:
23232673
3.

Human papillomavirus vaccination and the primary prevention of cancer: implications for survivors of childhood cancer.

Klosky JL, Foster RH, Hodges J, Peasant C, Gamble H, McDermott MJ, Rao P.

Stud Health Technol Inform. 2012;172:33-42.

PMID:
22910499
4.

Human papillomavirus (HPV) vaccines as an option for preventing cervical malignancies: (how) effective and safe?

Tomljenovic L, Spinosa JP, Shaw CA.

Curr Pharm Des. 2013;19(8):1466-87. Review.

PMID:
23016780
5.

Ladies first: should boys be vaccinated against HPV?

Leon R.

Can Fam Physician. 2008 Jul;54(7):967-8, 972-3. English, French. No abstract available.

6.

[Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].

Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.

Med Klin (Munich). 2007 Jul 15;102(7):515-23. German.

PMID:
17634869
7.

Human papillomavirus vaccines.

Satyaprakash A, Creed R, Ravanfar P, Mendoza N.

Dermatol Ther. 2009 Mar-Apr;22(2):150-7. doi: 10.1111/j.1529-8019.2009.01227.x. Review.

PMID:
19335726
8.

The introduction of the human papillomavirus vaccine - key issues.

Peate I.

Br J Nurs. 2009 Jan 22-Feb 11;18(2):86-9.

PMID:
19270605
9.

Human papillomavirus vaccine: widening the scope for cancer prevention.

No JH, Kim MK, Jeon YT, Kim YB, Song YS.

Mol Carcinog. 2011 Apr;50(4):244-53. doi: 10.1002/mc.20657. Review.

PMID:
21465574
10.

Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA.

Pharmacotherapy. 2011 Mar;31(3):280-97. doi: 10.1592/phco.31.3.280. Review.

PMID:
21361739
11.

Human papillomavirus and vaccination in cervical cancer.

Wang KL.

Taiwan J Obstet Gynecol. 2007 Dec;46(4):352-62. doi: 10.1016/S1028-4559(08)60004-2. Review.

12.

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.

Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, Perez G, Brown DR, Koutsky LA, Tay EH, Garcia PJ, Ault KA, Garland SM, Leodolter S, Olsson SE, Tang GW, Ferris DG, Paavonen J, Steben M, Bosch FX, Dillner J, Huh WK, Joura EA, Kurman RJ, Majewski S, Myers ER, Villa LL, Taddeo FJ, Roberts C, Tadesse A, Bryan JT, Lupinacci LC, Giacoletti KE, Sings HL, James MK, Hesley TM, Barr E, Haupt RM.

J Natl Cancer Inst. 2010 Mar 3;102(5):325-39. doi: 10.1093/jnci/djp534. Epub 2010 Feb 5.

PMID:
20139221
13.

Cervical cancer prevention in the human papilloma virus vaccine era.

Ghazal-Aswad S.

Ann N Y Acad Sci. 2008 Sep;1138:253-6. doi: 10.1196/annals.1414.030.

PMID:
18837904
14.

The GARDASIL vaccine can prevent cervical carcinoma caused by human papilloma virus (HPV) (results from our participation and from the study carried out in Greece).

Ansstasiou-Fotaki P, Deligeoroglou E, Kreatsas G.

Akush Ginekol (Sofiia). 2007;46(3):17-20. Bulgarian, English.

PMID:
18018777
15.

Less is more: a step in the right direction for human papillomavirus (HPV) vaccine implementation.

Wheeler CM.

J Natl Cancer Inst. 2011 Oct 5;103(19):1424-5. doi: 10.1093/jnci/djr354. Epub 2011 Sep 9. No abstract available.

PMID:
21908769
16.

Cost-consequences evaluation between bivalent and quadrivalent HPV vaccines in Italy: the potential impact of different cross-protection profiles.

Capri S, Gasparini R, Panatto D, Demarteau N.

Gynecol Oncol. 2011 Jun 1;121(3):514-21. doi: 10.1016/j.ygyno.2011.01.029. Epub 2011 Feb 19.

PMID:
21334734
17.

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives.

Castellsagué X, Schneider A, Kaufmann AM, Bosch FX.

Gynecol Oncol. 2009 Dec;115(3 Suppl):S15-23. doi: 10.1016/j.ygyno.2009.09.021. Epub 2009 Oct 12.

PMID:
19819540
18.
19.

Prevention strategies against the human papillomavirus: the effectiveness of vaccination.

Stanley M.

Gynecol Oncol. 2007 Nov;107(2 Suppl 1):S19-23. Review.

PMID:
17938013
20.

Age considerations when vaccinating against HPV.

Wright TC Jr, Huh WK, Monk BJ, Smith JS, Ault K, Herzog TJ.

Gynecol Oncol. 2008 May;109(2 Suppl):S40-7. doi: 10.1016/j.ygyno.2008.02.002. Review.

PMID:
18482558

Supplemental Content

Support Center